Cancer Gateway

Welcome to BioMed Central's Cancer Gateway, highlighting the latest articles we have published in this field. Content is continually updated, so please bookmark this page and ensure you check it regularly.

Articles

There has been an error retrieving the data. Please try again.
  • New molecular apocrine breast tumour signature

    A novel and simplified molecular and immunohistochemical signature has been described for molecular apocrine breast tumours which could help with easy identification in clinical practice.

    Breast Cancer Research 2013, 15:R37
  • Image attributed to: wikipedia (VashiDonsk)

    Characterizing leukemia genomics

    Carlos Lopez-Otin and colleagues review new developments in understanding the genomics of chronic lymphocytic leukemia, and discuss how genomic advances could benefit disease staging and treatment.

    BMC Medicine 2013, 11:124
  • Image attributed to: Wikipedia, Creative Commons 2.0

    CNS tumors in China

    The number of central nerve system tumors treated at a single center in China has increased substantially over the last 60 years, with lymphoma and hematopoietic neoplasm cases particularly high

    BMC Clinical Pathology 2013, 13:14
  • Image attributed to: from iStockphoto

    Improving prostate cancer diagnosis

    Caitlin Farris and Jeffrey Trimarchi discuss how a new non-invasive approach for personalized diagnosis of prostate cancer shows promise for the clinic, being both time- and cost-effective.

    Genome Medicine 2013, 5:35
  • Image attributed to: Cancer definition

    The importance of timing

    Celia Gomes comments on research showing human mesenchymal stem cells (MSCs) slow tumor growth in established murine tumors, whereas MSC administration appears to increase growth in newly formed tumors.

    Stem Cell Research & Therapy 2013, 4:42

AuthorMapper

Authors of BioMed Central cancer-related articles, by location

Powered by AuthorMapper.com

News and events

Biomarker Research, a new journal encompassing all aspects biomarker investigation, has now launched. Visit the journal website to read the first articles, including a review by co-Editor-in-Chief Delong Liu on the clinical applications of JAK inhibitors, and sign up for article alerts.

ez-reprint

Author profile

Wei Zhang

Director, Cancer Genomics Core Lab, University of Texas